The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp1293
EOSINOPHILIC ESOPHAGITIS: CLINICAL IMPLICATIONS OF DISEASE PROGRESSION
Date
May 9, 2023
Society: DDW
EoE is a chronic, type 2 inflammatory esophageal disease associated with dysphagia, regurgitation, and food impaction. Diagnostic delays result in disease progression, including stricture formation. Join us to explore beyond symptoms and uncover the essential role endoscopy and histology play in EoE diagnosis and management.
Sponsored by Sanofi and Regeneron
Concomitant esophageal dysmotility can be present in up to 2/3 of patients with EoE and GERD. Esophageal dysmotility contribute to symptoms in these patients and can be a reason for a suboptimal response to therapy…
BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
LIVE STREAM SESSION Despite advances in the understanding and treatment of eosinophilic esophagitis (EoE), there continue to be controversies in the management of both adult and pediatric patients, such as the role of routine allergy testing, need for surveillance endoscopy, and selection of initia…